Key result
Moderate to severe rejection after heart transplantation was associated with significantly increased endothelial cell binding of Pal-E and F VIII-related antigen compared to other cardiac conditions.
Why the study?
Does binding of endothelial-specific antibodies differ in myocarditis, dilated cardiomyopathy, and heart transplant rejection compared to normal donor hearts?
Cross-Sectional (n=56)
Does binding of endothelial-specific antibodies differ in myocarditis, dilated cardiomyopathy, and heart transplant rejection compared to normal donor hearts?
Endothelial cells show increased expression of specific antigens during heart transplant rejection, suggesting they are important targets in the rejection process.
Answers are grounded in this paper and cite their sources.
Endothelial antigen binding may mark severe rejection; leaves open whether these markers aid monitoring or therapy.
The role of endothelial cells in inflammatory heart disease and rejection after heart transplantation is only partly understood. To determine whether an immune reaction against endothelial cells occurs we examined endomyocardial biopsies from patients with myocarditis (n = 13), dilated cardiomyopathy (n = 23), no clinical rejection (n = 10) and moderate to severe rejection after heart transplantation (n = 10). These were compared to 'normal' donor hearts with monoclonal endothelial-specific antibodies EN4, Pal-E and F VIII-related antigen. Nearly all endothelial cells were stained positively with EN4. There were no significant changes in the binding of the antibodies except in rejection when Pal-E and F VIII-related antigen were significantly increased. It is concluded that apart from their possible role as antigen-presenting cells, endothelial cells are important targets in rejection after heart transplantation. Damage or cytolysis of endothelial cells may cause both altered transendothelial permeability and functional decrease in antigen presentation.
No takes yet. Share an insight, caveat, or question.
Hengstenberg et al. (1991) conducted a cross-sectional in Myocarditis, dilated cardiomyopathy, and heart transplantation rejection (n=56). Moderate to severe rejection after heart transplantation vs. Myocarditis, dilated cardiomyopathy, no clinical rejection, and normal donor hearts was evaluated on Binding of monoclonal endothelial-specific antibodies EN4, Pal-E and F VIII-related antigen. Moderate to severe rejection after heart transplantation was associated with significantly increased endothelial cell binding of Pal-E and F VIII-related antigen compared to other cardiac conditions.
Synapse has enriched 10 related papers. Consider them for comparative context: